Renal dysfunction after heart transplantation: Incidence, prognosis and risk factors

Journal of the Formosan Medical Association

Volumn 104, Issue 7, 2005, Pages 482-486

  Hsu, Ron Bin ^a   Chen, Robert J ^a   Lin, Cheng Hsin ^a   Chou, Nai Kuan ^a   Ko, Wen Je ^a   Wang, Shoei Shen ^a   Chu, Shu Hsun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Heart transplantation; Incidence; Kidney failure; Risk factors

Indexed keywords

CREATININE; CYCLOSPORIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART TRANSPLANTATION; HUMAN; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK FACTOR; SCHOOL CHILD; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL; BLOOD; CHILD; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; CHILD; CREATININE; CYCLOSPORINE; FEMALE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 24944525847     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Herlitz H, Lindelow B: Renal failure following cardiac transplantation. Nephrol Dial Transplant 2000;15:311-4.
2. Wilkinson AH, Cohen DJ: Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999;10:1136-44.
3. Brann WM, Bennett LE, Keck BM, et al: Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant 1998;17:374-82.
4. Taylor DO, Barr ML, Radovancevic B, et al: A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999;18:336-45.
5. English RF, Pophal SA, Bacanu SA, et al: Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients. Am J Transplant 2002;2:769-73.
6. Greenberg A, Egel JW, Thompson ME, et al: Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. Am J Kidney Dis 1987;9:12-22.
7. Goldstein DJ, Zuech N, Sehgal V, et al: Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 1997;63:664-8.
8. Hsu RB, Chu SH, Wang SS, et al. Low incidence of transplant coronary artery disease in Chinese heart recipients. J Am Coll Cardiol 1999;33:1573-7.
9. Billingham ME, Cary NR, Hammond ME, et al: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9:587-93.
10. Vossler MR, Ni H, Toy W, et al: Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation. J Heart Lung Transplant 2002;21:874-81.
11. Sehgal V, Radhakrishnan J, Appel GB, et al: Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension. Am J Kidney Dis 1995;26:193-201.
12. Garrido IP, Crespo-Leiro MG, Paniagua MJ, et al: Renal dysfunction after orthotopic heart transplantation: incidence, natural history, and risk factors. Transplant Proc 2003;35:2014-6.
13. El Kossi MM, Ibrahim A, Lock TJ, et al: Impact of cardiac transplantation on kidney function: a single-center experience. Transplant Proc 2003;35:1527-31.
14. Pradhan M, Leonard MB, Bridges ND, et al: Decline in renal function following thoracic organ transplantation in children. Am J Transplant 2002;2:652-7.
15. Abraham KA, McGorrian C, O'Kelly P, et al: The effect of pre-existing ischaemic heart disease on renal dysfunction in cardiac transplant recipients. Am J Transplant 2002;2:355-9.
16. Lindelow B, Bergh CH, Herlitz H, et al: Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol 2000;11:951-7.
17. Esposito C, Semeraro L, Bellotti N, et al: Risk factors for chronic renal dysfunction in cardiac allograft recipients. Nephron 2000;84:21-8.
18. van Gelder T, Balk AH, Zietse R, et al: Renal insufficiency after heart transplantation: a case-control study. Nephrol Dial Transplant 1998;13:2322-6.
19. Veillon S, Caillard S, Epailly E, et al: Chronic renal failure after cardiac transplantation: predictive factors and influence on mortality-results of a monocenter study in 141 patients. Transplant Proc 2002;34:2819-20.
20. Ruggenenti P, Perico N, Amuchastegui CS, et al: Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporine. Am J Kidney Dis 1994;24:549-53.
21. Tedoriya T, Keogh AM, Kusano K, et al: Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil. J Heart Lung Transplant 2002;21:976-82.
22. Aleksic I, Baryalei M, Busch T, et al: Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine. Transplantation 2000;69:1586-90.
23. Snell GI, Levvey BJ, Chin W, et al: Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 2002;21:540-6.
24. Myers BD, Newton L, Boshkos C, et al: Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 1988;46:694-703.
25. Waser M, Maggiorini M, Binswanger U, et al: Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients. J Heart Lung Transplant 1993;12:846-50.
26. Tomlanovich S, Golbetz H, Perlroth M, et al: Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis 1986;8:332-7.